Clinical observations indicate that large oral doses of castor oil are effective in reducing the time of coma resulting from acute intoxication with lipophilic drugs. It has been further suggested that the rate of removal of these drugs from the body is increased by castor oil. In order to investigate the effect of castor oil on the disposition of lipophilic drugs, five dogs were given toxic doses of methyprylon by intravenous infusion. Each dog was treated with a large oral dose of castor oil in a cross-over fashion. No significant difference was observed in the sleep times of the dogs treated with castor oil, or in the methyprylon pharmacokinetics compared to controls.
THE LENGTH OF COMA resulting from overdose with lipophilic sedatives and hypnotics bears a close relation to complication rate, the most important of which is respiratory infection. 1 Consequendy, specific measures to enhance the elimination rate of the drug from the body often accompany supportive treatment. For liphopbilic drugs, procedures such as haemodialysis, haemopeffusion or forced diuresis are usually ineffective, since most of the drug is located in the tissues and serum concentrations are low.
A novel approach to increasing the elimination rate of lipophilic drugs has been suggested by Diamond, et al.~'2 These investigators observed that patients overdosed with methyprylon had a significandy shorter coma time when treated with large oral doses of castor oil compared to matched patients who did not receive castor oil. The effect of the castor oil was attributed to a reduction in the extent of absorption and to an increase in the elimination rate of methyprylon, the latter effect being due to the drug diffusing from the circulation into the castor oil in the bowel lumen.
Animal studies were done to evaluate further effect of the castor oil on the absorption and disposition of another lipophilic drug, ethchlorvynol.I Serum drug concentrations were lower in animals treated with castor oil compared to controls. Although this may be largely explained by a reduction in drug absorption, it was also observed that the oral castor oil treatment reduced the elimination half-life by approximately 30 per cent in dogs receiving either 150 mg-kg -1 or 300 mg.kg -j ethchlorvynol. This finding compares with other reports in the literature demonstrating the ability of various orally administered sequestering agents to enhance the total body clearance of certain drugs 3,4 and fat-soluble environmental toxins. 5, 6 Unfortunately, in, the experiment described, both the drug and the castor oil were administered orally, making it difficult to ascertain the relative effect of the castor oil upon the absorption and the disposition of the drug. Because of the encouraging clinical results reported by Diamond, et al. 1 and others, 2 and the difficulties in inte~reting the results of their animal experiments I the present investigation was undertaken to clearly evaluate the effect of castor oil on the distribution and elimination of methyprylon in animals.
MATERIALS AND METHODS
Five female beagle dogs, each weighing about 10 kg were used. At least one week before the experiment a carmula was inserted into the right jugular vein of each dog as described by Mitala and Erickson. 7 At the time of experiment 150 mg.kg-~ of methyprylon was infused through the cannula over a 10 minute period. Patency of the 381 cannula and hydration of the dog were mainmined by slow intravenous drip of Normosol R in D5W. Drug was administered to each dog twice with at least a week between infusions. Using a cross-over design, one of the two treatments included 10 ml.kg -~ castor oil administered orally one hour after infusion. Sleep time was measured as the time between the loss and regaining of fighting reflex of the dog.
Immediately before the methyprylon infusion a blood sample was drawn. Additional blood samples were obtained at 5 min, 20 min, 30 min, 1 hr, 2 hr, 3 hr, 4 hr, and 6 hr after the end of the infusion. Plasma was separated and frozen until the time of assay.
Methyprylon and its major metabolite (3,3-diethyl-5 methyl-1,2,3,4-tetrahydro-2,4-piperidinedione) were assayed by high pressure liquid chromatography. To 2 ml of plasma, 25 )xl of internal standard (3.0 mg pyrithylidione/250 ml distilled water) was added. The drug, metabolite and internal standard were extracted into 10 ml ether which was then evaporated to dryness in a stream of nitrogen. The residue was dissolved in 25 Isl of the mobile phase of the HPLC (hexane/tetrahydrofuran/ethanol, 930:50:20) and injected onto the column. Details of the assay are to be published elsewhere.
Plasma drug concentration-time data were fitted to a two compartment pharmacokinetic model using NONLIN. s used to determine the half-life, the value of this parameter in dogs not treated with castor oil is the same as that in the dogs receiving castor oil, indicating that castor oil treatment has no effect on the elimination rate of ethchlorvynol. The data of these investigators also suggest that while castor oil clearly reduces the extent of absorption, paradoxically it appears to increase the rate of absorption, since absorption appears to be complete by about 15 hours in the dogs receiving castor oil. This may be due to stimulation of gastrointestinal motility by the castor oil or simply increased gastric emptying resulting from the administration of a large volume of fluid. 9 RESULTS 
AND DISCUSSION CONCLUSION
Sleep times of dogs receiving intravenous methyprylon alone and methyprylon followed by oral castor oil are shown in Table I . Statistical analysis of the data failed to support any significant difference between the two sets of sleep times. Average pharmacokinetic parameters for methyprylon in controls and dogs treated with castor oil are reported in Table II . No statistically significant difference was observed between any pair of parameters. Castor oil, therefore appears to have no effect upon the distribution or the rate of elimination of methyprylon in the dog.
These results appear to conflict with the findings of Diamond, et al. i with ethchlorvynol. However visual examination of the serum drug concentration-time data (Figure 2 in their paper) suggests that in the dogs not treated with castor oil, absorption of the drug continues for approximately 30 hours. A useful determination of the half-life can only be made using data points after this time. When these later points only are Both the results of the present investigation with methyprylon and the re-evaluated findings of a previous study with ethchlorvynol suggest that orally administered castor oil does not affect the elimination rate of lipophilic drugs. The dramatic clinical improvement observed in patients treated with castor oil for lipophilic drug overdose may be attributed to the effect of castor oil on the extent of absorption of these drugs.
Castor oil is widely recognized as a useful agent in the treatment of lipophilic drug overdose. to It is important to understand the mechanism of action of this agent to ensure its rational use. The present study indicates that if most of the ingested dose of lipophilic drug has been absorbed, (as in the case of a liquid dosage form such as an elixir) castor oil will not bring about a reduction in the amount of drug in the body. A possible exception to this would be in the treatment of overdose with drugs which undergo enterohepatic cycling. 3 
